Semaglutide improves cardiovascular health in users in addition to causing weight loss: Study Medha Baranwal31 May 2023 11:15 AM ISTUSA: Semaglutide use in obese/overweight patients may decrease the 10-year risk of atherosclerotic cardiovascular disease (ASCVD) in addition to...
Semaglutide use in overweight/obese patients tied to reduced CVD risk Dr. Kamal Kant Kohli24 May 2023 10:00 AM ISTUSA: Semaglutide use in overweight/obese patients is associated with a decrease in the 10-year risk of atherosclerotic cardiovascular disease (ASCVD),...
Semaglutide use tied to significant weight loss in multicentre, one-year real-world study Dr. Kamal Kant Kohli23 May 2023 11:00 AM ISTUSA: Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is shown to be effective in a multicentre, 1-year-long real-world study...
Semaglutide use in adolescents can reduce liver enzymes indicative of liver damage: STEP TEENS trial analysis Dr. Kamal Kant Kohli20 May 2023 11:30 AM ISTAustria: Semaglutide use may significantly reduce the liver enzymes indicative of liver damage, a new substudy of the STEP TEENS trial has...
Medical Bulletin 19/May/2023 Isra Zaman19 May 2023 4:30 PM ISTHere are the top medical news for the day:Study finds marijuana users to be thrice more likely to develop peripheral artery diseaseMarijuana use has...
Single one-hour endoscopic procedure could potentially control type 2 diabetes Dr. Kamal Kant Kohli2 May 2023 10:45 AM ISTResearchers have developed a procedure that uses controlled electrical pulses to induce changes to the lining of the first part of the small intestine...
Semaglutide 1.0 mg weekly bests Liraglutide 3.0 mg daily for post bariatric surgery weight recurrence Dr. Mahalakshmi Sivashankaran23 April 2023 8:15 PM ISTUSA: Semaglutide has been shown to be more effective than liraglutide in treating post-metabolic and bariatric surgery (MBS) weight recurrence,...
Novo Nordisk raises full-year forecast on GLP-1 drug sales Ruchika Sharma16 April 2023 10:00 AM ISTThe guidance upgrade also partly reflected higher expected sales in the U.S. of its Ozempic diabetes drug, which is based on the same active...
Novo Nordisk diabetes drug Ozempic back on shelves in US after months of shortage Ruchika Sharma19 March 2023 1:00 PM ISTUS: Novo Nordisk's best-selling diabetes treatment drug Ozempic is back on the shelves in the United States after months of shortage, the U.S....
Switching from liraglutide to semaglutide leads to weight loss and improves blood sugar control in type 2 diabetes Dr Kartikeya Kohli15 March 2023 11:30 AM ISTJapan: Switching from once-daily liraglutide to once-weekly semaglutide 0.5 mg notably improves blood sugar control and body weight versus switching...
Semaglutide advisable option for preservation of beta cell function in diabetes patients Aditi8 Feb 2023 11:15 AM ISTItaly: An original research article published in Frontiers in Endocrinology has mentioned that Semaglutide preserves the functioning of β-cell. It...
Semaglutide helps control food cravings in addition to weight loss in overweight adults Medha Baranwal28 Jan 2023 11:30 AM ISTCanada: Semaglutide 2.4 mg improves short- and longer-term control of eating in adults with obesity/overweight, says a recent study published in...
